lamotrigine has been researched along with Anxiety in 13 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind crossover study of a low dose (15 mg, 'placebo') and an active dose (195 mg) of methylene blue in patients with bipolar disorder treated with lamotrigine." | 9.24 | Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. ( Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C, 2017) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 7.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "We describe the case of a pregnancy healthy outcome after in utero consecutive exposure to lamotrigine and citalopram." | 7.74 | Consecutive exposure to lamotrigine and citalopram during pregnancy. ( Gentile, S; Vozzi, F, 2007) |
| "We assessed the effects of the anticonvulsants lamotrigine, valproate and carbamazepine in an animal model of anxiety." | 7.73 | Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? ( Bright, JL; Harrington, NR; Mirza, NR; Stanhope, KJ; Wyatt, A, 2005) |
| "We conducted a double-blind crossover study of a low dose (15 mg, 'placebo') and an active dose (195 mg) of methylene blue in patients with bipolar disorder treated with lamotrigine." | 5.24 | Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. ( Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C, 2017) |
| " In this study, the pentylenetetrazole seizure test (PTZ) was performed to assess the effectiveness of four new ASDs: lamotrigine (LTG), topiramate (TPM), felbamate (FBM), and levetiracetam (LEV) in the subsequent stages of seizures in adult fish." | 4.02 | Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish. ( Doboszewska, U; Guz, L; Pieróg, M; Poleszak, E; Serefko, A; Socała, K; Szopa, A; Wlaź, P; Wyska, E, 2021) |
| "We investigated the possible roles of the prelimbic medial prefrontal cortex (PL) in the regulation of anxiety-like behaviors by pharmacologically activating the terminals of neuronal inputs or postsynaptic efferent neurons with a sodium channel activator veratrine." | 3.80 | Activation of the prelimbic medial prefrontal cortex induces anxiety-like behaviors via N-Methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in mice. ( Inagaki, M; Ohashi, M; Oka, J; Saitoh, A; Sugiyama, A; Suzuki, S; Tsukagoshi, M; Yamada, M, 2014) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 3.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "We describe the case of a pregnancy healthy outcome after in utero consecutive exposure to lamotrigine and citalopram." | 3.74 | Consecutive exposure to lamotrigine and citalopram during pregnancy. ( Gentile, S; Vozzi, F, 2007) |
| "We assessed the effects of the anticonvulsants lamotrigine, valproate and carbamazepine in an animal model of anxiety." | 3.73 | Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? ( Bright, JL; Harrington, NR; Mirza, NR; Stanhope, KJ; Wyatt, A, 2005) |
| "Lamotrigine is a new anticonvulsant with few side effects that may have mood-stabilizing and elevating effects." | 2.68 | The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. ( Sachs, G; Sporn, J, 1997) |
| "Levetiracetam was independently associated with anger/aggression, nervousness/agitation, upset stomach, depression, and sleep disturbance; lamotrigine with nervousness/agitation, upset stomach, and difficulty concentrating; and valproic acid with upset stomach and shaky hands." | 1.43 | Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study. ( Fidzinski, P; Gaus, V; Holtkamp, M; Kowski, AB; Losch, F; Weissinger, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Pieróg, M | 1 |
| Socała, K | 1 |
| Doboszewska, U | 1 |
| Wyska, E | 1 |
| Guz, L | 1 |
| Szopa, A | 1 |
| Serefko, A | 1 |
| Poleszak, E | 1 |
| Wlaź, P | 1 |
| Koneval, Z | 1 |
| Knox, KM | 1 |
| White, HS | 1 |
| Barker-Haliski, M | 1 |
| Saitoh, A | 1 |
| Ohashi, M | 1 |
| Suzuki, S | 1 |
| Tsukagoshi, M | 1 |
| Sugiyama, A | 1 |
| Yamada, M | 2 |
| Oka, J | 1 |
| Inagaki, M | 1 |
| Kowski, AB | 1 |
| Weissinger, F | 1 |
| Gaus, V | 1 |
| Fidzinski, P | 1 |
| Losch, F | 1 |
| Holtkamp, M | 1 |
| Alda, M | 1 |
| McKinnon, M | 1 |
| Blagdon, R | 1 |
| Garnham, J | 1 |
| MacLellan, S | 1 |
| O'Donovan, C | 1 |
| Hajek, T | 1 |
| Nair, C | 1 |
| Dursun, S | 1 |
| MacQueen, G | 1 |
| Foreman, MM | 1 |
| Hanania, T | 1 |
| Eller, M | 1 |
| Moretti, M | 1 |
| Meltzer-Brody, SE | 1 |
| Zolnoun, D | 1 |
| Steege, JF | 1 |
| Rinaldi, KL | 1 |
| Leserman, J | 1 |
| Maschio, M | 1 |
| Dinapoli, L | 1 |
| Sperati, F | 1 |
| Pace, A | 1 |
| Fabi, A | 1 |
| Vidiri, A | 1 |
| Pompili, A | 1 |
| Carapella, CM | 1 |
| Mirza, NR | 1 |
| Bright, JL | 1 |
| Stanhope, KJ | 1 |
| Wyatt, A | 1 |
| Harrington, NR | 1 |
| Kemp, S | 1 |
| Feely, M | 1 |
| Hay, A | 1 |
| Wild, H | 1 |
| Cooper, C | 1 |
| Gentile, S | 1 |
| Vozzi, F | 1 |
| Sporn, J | 1 |
| Sachs, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder[NCT00214877] | Phase 3 | 40 participants (Anticipated) | Interventional | 2003-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lamotrigine and Anxiety
| Article | Year |
|---|---|
[Trichotillomania and comorbidity--lamotrigine in a new perspective].
Topics: Adolescent; Adult; Antidepressive Agents; Antimanic Agents; Anxiety; Behavior, Addictive; Bipolar Di | 2008 |
3 trials available for lamotrigine and Anxiety
| Article | Year |
|---|---|
Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study.
Topics: Adult; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Cross-Over Studies; Depression; Double-Blin | 2017 |
Open-label trial of lamotrigine focusing on efficacy in vulvodynia.
Topics: Adult; Aged; Analgesics; Anxiety; Comorbidity; Depression; Dose-Response Relationship, Drug; Female; | 2009 |
The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.
Topics: Adult; Anticonvulsants; Anxiety; Bipolar Disorder; Drug Resistance; Female; Humans; Lamotrigine; Mal | 1997 |
9 other studies available for lamotrigine and Anxiety
| Article | Year |
|---|---|
Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish.
Topics: Age Factors; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Dose-Response Relationship, Dru | 2021 |
Lamotrigine-resistant corneal-kindled mice: A model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery.
Topics: Animals; Anticonvulsants; Anxiety; Body Weight; Cornea; Disease Models, Animal; Dose-Response Relati | 2018 |
Activation of the prelimbic medial prefrontal cortex induces anxiety-like behaviors via N-Methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in mice.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anxiety; Behavior, Animal; Dizocilpine Maleate; Excit | 2014 |
Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Depression; Drug-Related Side Effects and Adve | 2016 |
Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Lamotrigine; Male; Maze Learning; Mice; Pun | 2009 |
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Benzodiazepines; Brain Neoplasms; Carbamazepine; Clobazam; Dr | 2012 |
Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Calcium Channel Agonists; Calcium Channel Bl | 2005 |
Psychological factors and use of antiepileptic drugs: pilot work using an objective measure of adherence.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Anxiety; Culture; Depression; Drug Monitoring; Drug Therap | 2007 |
Consecutive exposure to lamotrigine and citalopram during pregnancy.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Depression; Drug Administration Sched | 2007 |